Page last updated: 2024-12-06

hordenine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Hordenine is a naturally occurring alkaloid found in various plants, including barley, rye, and oats. It is a sympathomimetic amine that exhibits a range of pharmacological effects. Hordenine is synthesized from the amino acid tyrosine through a series of enzymatic steps. It has been shown to have stimulant effects on the central nervous system, potentially increasing alertness and reducing fatigue. Hordenine is also believed to have anti-inflammatory properties and may play a role in regulating blood pressure. Research on hordenine focuses on its potential therapeutic applications, particularly its effects on cognitive function, mood, and physical performance. Studies are also underway to investigate its role in plant defense mechanisms and its potential as a natural insecticide.'

Cross-References

ID SourceID
PubMed CID68313
CHEMBL ID505789
CHEBI ID5764
SCHEMBL ID36798
MeSH IDM0051458

Synonyms (85)

Synonym
n,n-dimethyltyramine
p-(2-dimethylaminoethyl)phenol
CHEBI:5764 ,
n,n-dimethyl-2-(4-hydroxyphenyl)ethylamine
n,n-dimethyl-4-hydroxy-beta-phenethylamine
phenol, 4-[2-(dimethylamino)ethyl]-
phenol, p-[2-(dimethylamino)ethyl]-
3595-05-9
539-15-1
hordenine ,
4-[2-(dimethylamino)ethyl]phenol
C06199
NCGC00160162-02
NCGC00160162-01
AC-11302
AKOS000277358
4-(2-dimethylaminoethyl)phenol
CHEMBL505789
eremursine
FT-0653994
FT-0695035
NCGC00160162-03
anhaline
unii-k3489ca082
einecs 208-710-4
k3489ca082 ,
dtxsid2046096 ,
cas-539-15-1
tox21_111748
dtxcid0026096
A829829
BCP9000255
H1351
4-hydroxy-n,n-dimethylphenethylamine
n-dimethyl-4-hydroxyphenylethylamine
FT-0627091
FT-0603459
hordenin
hordenine [who-dd]
peyocactine
n,n-dimethyl-p-hydroxyphenethylamine
p-hydroxy-n,n-dimethylphenethylamine
hordenine [inci]
phenol, p-(2-(dimethylamino)ethyl)-
anhalin
hordenine [mi]
cactine
ordenina
p-(2-(dimethylamino)ethyl)phenol
n,n-dimethyl-4-hydroxy-.beta.-phenethylamine
S2385
SCHEMBL36798
NCGC00160162-04
tox21_111748_1
ordenine
p-[2-(dimethylamino)ethyl]phenol
4-[2-(dimethylamino)ethyl]phenol #
4-(2-dimethylaminoethyl)-phenol
4-(2-(dimethylamino)ethyl)phenol
AC-34131
Q-100610
GS-0924
mfcd00051462
2-(4-hydroxyphenyl)-n,n-dimethylethylamine
eremursin
sr-05000002241
SR-05000002241-2
hordenine, >=97.0% (hplc)
hordenine, analytical standard
HMS3656M13
hordetin
SW219673-1
BCP22859
Q119915
BRD-K93631643-065-01-1
AMY39490
STL565154
CCG-266321
hordenine (sulfate)
ordenina;peyocactine
ordenina (sulfate); peyocactine (sulfate)
CS-0007797
HY-N0113
n,n-dimethyl-4-hydroxyphenylethylamine
EN300-7358623

Research Excerpts

Overview

Hordenine (HOR) is a phenolic phytochemical marketed as a dietary supplement. It is found in cereals and germinated barley, as well as in beer, a widely consumed beverage.

ExcerptReferenceRelevance
"Hordenine (HOR) is a phenolic phytochemical marketed as a dietary supplement found in cereals and germinated barley, as well as in beer, a widely consumed beverage."( Hordenine improves Parkinsonian-like motor deficits in mice and nematodes by activating dopamine D2 receptor-mediated signaling.
Chen, Z; Fan, S; Gao, M; Huang, C; Huang, X; Jiang, X; Li, F; Li, H; Li, W; Luo, L; Wang, G; Wu, X; Zhang, X; Zhang, Y; Zhou, Z; Zhu, J, 2023
)
3.07
"Hordenine is an active compound found in several foods, herbs and beer. "( Selective extraction based on poly(MAA-VB-EGMDA) monolith followed by HPLC for determination of hordenine in plasma and urine samples.
An, J; Chen, Y; Meng, J; Zou, J, 2015
)
2.08
"Hordenine is an active compound found in several foods, herbs and beer. "( Validated UPLC-MS/MS method for determination of hordenine in rat plasma and its application to pharmacokinetic study.
Geng, P; Huang, X; Ma, J; Wang, S; Wang, X; Wen, C; Yu, L; Zhou, Y, 2015
)
2.11
"Hordenine is an ingredient of some plants which are used as feed for animals, i.e. "( [Pharmacological effects of hordenine].
Hapke, HJ; Strathmann, W, 1995
)
2.03
"Hordenine is an alkaloid occurring naturally in grains, sprouting barley, and certain grasses. "( Hordenine: pharmacology, pharmacokinetics and behavioural effects in the horse.
Blake, JW; Chang, SL; Ewing, A; Frank, M; Tai, CL; Tobin, T; Weckman, TJ; Wood, T; Woods, WE, 1990
)
3.16

Treatment

Hordenine treatment enhanced the susceptibility of the preformed biofilms to ciprofloxacin by reducing the production of extracellular polysaccharides. The treatment also changed the permeability of membranes, as evidenced by the scattered appearance and dominant red fluorescence.

ExcerptReferenceRelevance
"Hordenine treatment notably enhanced the susceptibility of the preformed biofilms to ciprofloxacin by reducing the production of extracellular polysaccharides, destroying the architecture of biofilms, and changing the permeability of membranes, as evidenced by the scattered appearance and dominant red fluorescence in the combination-treated biofilms."( Inhibition of Quorum Sensing and Virulence in Serratia marcescens by Hordenine.
Chen, HJ; Jia, AQ; Jiang, H; Luo, HZ; Ruan, LY; Wang, JS; Zhou, JW, 2019
)
1.47
"Hordenine treatment resulted in the destruction of QS system in P."( Metabolomic analysis of quorum sensing inhibitor hordenine on Pseudomonas aeruginosa.
Jia, AQ; Muhammad, J; Sun, B; Wadood, A; Wang, JS; Yang, R; Zhou, JW, 2019
)
1.49

Pharmacokinetics

ExcerptReferenceRelevance
" Kinetics of plasma concentration satisfied the concept of a two compartment open system, with an alpha-phase half-life of about 3 mins, and a beta-phase half-life of about 35 mins."( Hordenine: pharmacology, pharmacokinetics and behavioural effects in the horse.
Blake, JW; Chang, SL; Ewing, A; Frank, M; Tai, CL; Tobin, T; Weckman, TJ; Wood, T; Woods, WE, 1990
)
1.72
" The method was successfully applied to pharmacokinetic study of hordenine after oral and intravenous administration."( Validated UPLC-MS/MS method for determination of hordenine in rat plasma and its application to pharmacokinetic study.
Geng, P; Huang, X; Ma, J; Wang, S; Wang, X; Wen, C; Yu, L; Zhou, Y, 2015
)
0.91

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" However, the high bioavailability may be reduced by the observed efflux transport of hordenine from the bloodstream back into the intestinal lumen and by first pass metabolism in intestinal epithelial cells."( Permeability of dopamine D2 receptor agonist hordenine across the intestinal and blood-brain barrier in vitro.
Behrens, M; Esselen, M; Hahn, M; Humpf, HU; Langer, K; Lindemann, V; Mulac, D, 2022
)
1.2

Dosage Studied

ExcerptRelevanceReference
" Typically, dosed horses showed a flehmen response and defecated within 60 secs."( Hordenine: pharmacology, pharmacokinetics and behavioural effects in the horse.
Blake, JW; Chang, SL; Ewing, A; Frank, M; Tai, CL; Tobin, T; Weckman, TJ; Wood, T; Woods, WE, 1990
)
1.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phenethylamine alkaloid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLS proteinHomo sapiens (human)Potency12.58930.35487.935539.8107AID624170
GLI family zinc finger 3Homo sapiens (human)Potency21.97430.000714.592883.7951AID1259369; AID1259392
EWS/FLI fusion proteinHomo sapiens (human)Potency18.65480.001310.157742.8575AID1259253
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency6.00700.000214.376460.0339AID720691
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (40)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1135266Inhibition of norepinephrine release in sc dosed mouse heart administered 60 mins before [3H]-norepinephrine challenge1977Journal of medicinal chemistry, May, Volume: 20, Issue:5
N-(2,4,5-Trihydroxyphenehtyl)normetazocine, a potential irreversible inhibitor of the narcotic receptor.
AID1414065Inhibition of Pseudomonas aeruginosa quorum sensing system assessed as decrease in C4-HSL production at 6 mM relative to control2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Pseudomonas aeruginosa Quorum Sensing Systems as Drug Discovery Targets: Current Position and Future Perspectives.
AID1414095Inhibition of Pseudomonas aeruginosa quorum sensing system assessed as decrease in 3OC12-HSL production at 6 mM relative to control2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Pseudomonas aeruginosa Quorum Sensing Systems as Drug Discovery Targets: Current Position and Future Perspectives.
AID402352Cytotoxicity against human A2780 cells2005Journal of natural products, Jun, Volume: 68, Issue:6
Alkaloids and aromatics of Cyathobasis fruticulosa (Bunge) Aellen.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (18.46)18.7374
1990's3 (4.62)18.2507
2000's5 (7.69)29.6817
2010's25 (38.46)24.3611
2020's20 (30.77)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.70 (24.57)
Research Supply Index4.19 (2.92)
Research Growth Index5.52 (4.65)
Search Engine Demand Index86.18 (26.88)
Search Engine Supply Index2.36 (0.95)

This Compound (48.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.54%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other64 (98.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]